Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

NCT00440947 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

515

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus I
HIV Infection

Interventions

DRUG: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV) + ritonavir (/r)
DRUG: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV)

Sponsor

ViiV Healthcare

Collaborators

[object Object]